{"status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved.", "response": {"docs": [{"word_count": 1958, "slideshow_credits": null, "multimedia": [], "news_desk": "National Desk", "pub_date": "1999-01-28T00:00:00Z", "source": "The New York Times", "web_url": "http://www.nytimes.com/1999/01/28/us/for-school-nurses-more-than-tending-the-sick.html", "blog": [], "_id": "4fd20a078eb7c8105d776ba5", "headline": {"main": "For School Nurses, More Than Tending the Sick"}, "subsection_name": null, "abstract": "School systems in Boston and elsewhere are engaged in debate over changing role of school nurses as students' needs have become more complex; nurses are struggling to juggle triage of sick-feeling students with growing load of other duties; many say jobs are changing because American life has changed; mention increased diagnoses of psychiatric illness and learning disabilities and more drugs to treat such disorders; point to policies of 'inclusion' that have populated public schools with scatterings of chronically ill children who would formerly have gone to special institutions; voice impression that behavioral problems right up to classroom violence have worsened, requiring more collaboration by nurses with school teams; express growing sense that school is, in part, health care provider, leaned on heavily by working parents; debate over their role in Boston school system discussed; photo (M)", "section_name": "Education; Health; U.S.", "byline": {"original": "By CAREY GOLDBERG", "person": [{"rank": 1, "firstname": "Carey", "lastname": "GOLDBERG", "role": "reported", "organization": ""}]}, "print_page": "20", "document_type": "article", "type_of_material": "News", "keywords": [{"value": "BOSTON (MASS)", "name": "glocations"}, {"value": "EQUAL EDUCATIONAL OPPORTUNITIES", "name": "subject"}, {"value": "NURSING AND NURSES", "name": "subject"}, {"value": "EDUCATION AND SCHOOLS", "name": "subject"}, {"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}, {"value": "DISCRIMINATION", "name": "subject"}, {"value": "MENTAL HEALTH AND DISORDERS", "name": "subject"}, {"value": "MEDICINE AND HEALTH", "name": "subject"}, {"value": "SPECIAL EDUCATION (HANDICAPPED)", "name": "subject"}, {"value": "HANDICAPPED", "name": "subject"}], "lead_paragraph": "Ritalin, Ritalin, seizure drugs, Ritalin. So goes the rhythm of noontime for Mary Jane Kemper, nurse at the Donald McKay School in East Boston, as she trots her tray of brown plastic vials and paper water cups from class to class, dispensing pills into outstretched young palms. In this ever-more-pharmacologized society, hers is a more common and demanding American school routine, as nurses, once known mainly as providers of Band-Aids, cots and hearing tests, find themselves increasingly in thrall to millions of midday doses, mainly for attention deficit disorder, but also for psychiatric and chronic illnesses.", "snippet": "Ritalin, Ritalin, seizure drugs, Ritalin. So goes the rhythm of noontime for Mary Jane Kemper, nurse at the Donald McKay School in East Boston, as she trots her tray of brown plastic vials and paper water cups from class to class, dispensing pills..."}, {"word_count": 1565, "slideshow_credits": null, "multimedia": [], "news_desk": "Business/Financial Desk", "pub_date": "1999-01-25T00:00:00Z", "source": "The New York Times", "web_url": "http://www.nytimes.com/1999/01/25/business/patients-facing-steep-increases-drug-costs-insurers-seek-contain-rising-outlays.html", "blog": [], "_id": "4fd218928eb7c8105d795aa7", "headline": {"main": "Patients Facing Steep Increases in Drug Costs as Insurers Seek to Contain Rising Outlays"}, "subsection_name": null, "abstract": "Patients across nation are facing steep rises in out-of-pocket charges for prescription drugs, reversing recent trend toward more liberal coverage; standard co-payments are often doubling; increases of 300 percent or more are appearing for some drugs that are not on insurers' lists of approved drugs as insurers increasingly refuse to endorse more costly new versions of life-sustaining remedies when cheaper alternatives exist; table (M)", "section_name": "Health; Business", "byline": {"original": "By MILT FREUDENHEIM", "person": [{"rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM", "role": "reported", "organization": ""}]}, "print_page": "18", "document_type": "article", "type_of_material": "News", "keywords": [{"value": "HEALTH INSURANCE", "name": "subject"}, {"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}, {"value": "PRICES (FARES, FEES AND RATES)", "name": "subject"}], "lead_paragraph": "Patients across the country are facing steep increases in out-of-pocket charges for prescription drugs, reversing a recent trend toward more liberal coverage. Standard co-payments are often doubling for drugs that patients have been using for years. But even bigger increases -- of 300 percent or more -- are appearing for some remedies that are not on insurers' lists of approved drugs.", "snippet": "Patients across the country are facing steep increases in out-of-pocket charges for prescription drugs, reversing a recent trend toward more liberal coverage.    Standard co-payments are often doubling for drugs that patients have been using for..."}], "meta": {"offset": 0, "hits": 2, "time": 79}}}